Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
The hemoglobin A1c testing devices market is experiencing significant growth as the need for effective diabetes management intensifies globally. Advances in technology and increasing awareness about glycemic control are driving demand for reliable and convenient testing solutions. Let’s explore the current market size, key growth drivers, segmentation, industry trends, competitive landscape, and regional outlook shaping this sector’s future.
Market Size and Growth Prospects in the Hemoglobin A1c Testing Devices Market
The hemoglobin A1c testing devices market has rapidly expanded, with its value expected to rise from $2.08 billion in 2025 to $2.32 billion in 2026, reflecting a strong compound annual growth rate (CAGR) of 11.7%. This earlier growth phase was largely influenced by the increasing prevalence of diabetes, wider use of routine blood glucose monitoring, improved accessibility to lab diagnostics, heightened awareness about glycemic control, and the adoption of standardized diabetes testing procedures. Looking ahead, the market is forecasted to continue its upward trajectory, reaching $3.53 billion by 2030 at a CAGR of 11.1%. This anticipated growth is fueled by expanding demand for home-based diabetes monitoring, integration of AI-driven analytics, the rise of remote patient monitoring technologies, a growing focus on personalized diabetes care, and the acceptance of smart diagnostic devices. Key trends expected to define the market include greater adoption of point-of-care HbA1c testing, increased use of portable and handheld devices, stronger connectivity with digital diabetes management platforms, development of rapid and highly accurate assays, and a stronger emphasis on patient-centered monitoring.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9077&type=smp
Primary Factors Contributing to the Hemoglobin A1c Testing Devices Market Growth
The rising incidence of diabetes worldwide is a major factor propelling the hemoglobin A1c testing devices market. Diabetes, a chronic metabolic disease characterized by elevated blood sugar levels, requires ongoing monitoring. Hemoglobin A1c testing provides essential information about average blood glucose levels over time, aiding in diagnosing type 2 diabetes, prediabetes, and managing diabetes effectively. This testing enables patients and healthcare providers to make informed treatment decisions to prevent complications. For example, in June 2024, the UK’s National Health Service reported that in 2023, over half a million additional people in England were identified as at risk for developing type 2 diabetes, increasing the number of individuals with prediabetes registered with general practitioners to 3,615,330—a nearly 20% rise compared to 2022. Such statistics underscore the growing patient population needing HbA1c testing devices.
Expanding Routine Blood Glucose Testing Drives Demand
The widespread use of routine blood glucose monitoring practices has further supported market growth. More frequent testing and monitoring have become integral to managing diabetes, encouraging the adoption of advanced devices that provide accurate and timely results. Improved laboratory diagnostic capabilities have also made HbA1c testing more accessible and reliable for both patients and healthcare professionals.
Access The Complete Hemoglobin A1c Testing Devices Market Report:
Detailed Segmentation of the Hemoglobin A1c Testing Devices Market
This market is segmented by type, technology, and end use to provide a comprehensive understanding of its structure:
1) By Type:
– Bench Top Devices
– Handheld Devices
2) By Technology:
– Ion-Exchange High-Performance Liquid Chromatography (HPLC)
– Immunoassay
– Boronate Affinity Chromatography
– Direct Enzymatic Assay
– Other Technologies
3) By End Use:
– Hospitals
– Pharmaceuticals
– Medical Devices
– Laboratory Testing
Further subcategories include:
– Bench Top Devices: Automated Hemoglobin A1c Analyzers, Laboratory-Grade Analyzers, Multi-Parameter Testing Devices
– Handheld Devices: Portable HbA1c Testers, Point-of-Care Testing Devices, Smartphone-Integrated Testing Devices
Innovative Industry Trends Shaping the Future of Hemoglobin A1c Testing Devices
Key players in the hemoglobin A1c testing devices market are focusing on innovation, particularly developing at-home or micro-sample collection kits to meet growing demand. These kits enable patients to conveniently collect small blood samples at home via finger-pricks, stabilize the sample for transport, and send it to certified labs for accurate analysis. This approach supports decentralized care models, telehealth services, and patient preferences for easy, cost-effective monitoring tools. For instance, in February 2023, Hurdle, a US-based diagnostics-as-a-service company, introduced an at-home HbA1c test through its Chronomics direct-to-consumer platform. The kit includes lancets and sample cards, secure registration, and courier service to CLIA-certified laboratories. It offers lab-grade results with typical turnaround times of around three days, integrated explanations, and optional one-on-one consultations with healthcare professionals, combining convenience with clinical accuracy.
Major Competitors and Market Leaders in Hemoglobin A1c Testing Devices
Several prominent companies drive the hemoglobin A1c testing devices market, including:
– Arkray Inc
– Abbott Laboratories
– Polymer Technology Systems Inc
– Bio-Rad Laboratories Inc
– Menarini Group
– F Hoffmann-La Roche AG
– Siemens Healthineers AG
– Tosoh Corporation
– Trinity Biotech plc
– Transasia Bio-Medicals Limited
– Beckman Coulter Inc
– Diazyme Laboratories Inc
– EKF Diagnostics Holdings plc
– HemoCue AB
– OSANG Healthcare Co Ltd
– Danaher
– Thermo Fisher Scientific Inc.
– PTS Diagnostics India Private Limited
– Nova Biomedical
– Randox Laboratories Ltd.
– ACON Laboratories Inc.
– DiaSys Diagnostic Systems GmbH
– Erba Mannheim
– Green Cross Medical Science Corp.
– Infopia Co. Ltd.
– TaiDoc Technology Corporation
– Werfen
– Zhejiang Orient Gene Biotech Co. Ltd.
Regional Market Leadership and Growth Projections for Hemoglobin A1c Testing Devices
In 2025, North America held the largest share in the hemoglobin A1c testing devices market due to advanced healthcare infrastructure and high diabetes prevalence. Meanwhile, Asia-Pacific is projected to be the fastest-growing region during the forecast period. Other regions covered in the analysis include South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a global perspective on market trends and opportunities.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
